Alkem Laboratories Ltd.(IN:ALKEM)
₹5,110.00-225.00 (-4.22%)
IN:ALKEM
Alkem Laboratories Ltd. financials statements
₹5,110.00
At close:-225.00 (-4.22%)
Want to see IN:ALKEM full AI Analyst Report?
Alkem Laboratories Ltd. (ALKEM) Financial Statements
2 Followers
Alkem Laboratories Ltd. Financial Overview
Alkem Laboratories Ltd.'s market cap is currently ₹637.88B. The company's EPS TTM is ₹180.25; its P/E ratio is 29.64; and it has a dividend yield of 1.04%. Alkem Laboratories Ltd. is estimated to report earnings on February 5, 2027, and the estimated EPS forecast is ₹52.60. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ₹ 147.12B | ₹ 128.05B | ₹ 124.39B | ₹ 114.40B | ₹ 105.12B |
| Gross Profit | ₹ 96.19B | ₹ 79.47B | ₹ 74.07B | ₹ 64.58B | ₹ 62.29B |
| Operating Income | ₹ 26.23B | ₹ 21.84B | ₹ 19.85B | ₹ 13.34B | ₹ 17.69B |
| EBITDA | ₹ 34.14B | ₹ 29.71B | ₹ 24.18B | ₹ 17.09B | ₹ 21.89B |
| Net Income | ₹ 23.02B | ₹ 21.65B | ₹ 17.96B | ₹ 9.84B | ₹ 16.46B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ₹ 40.65B | ₹ 37.78B | ₹ 42.70B | ₹ 11.43B | ₹ 13.13B |
| Total Assets | ₹ 208.73B | ₹ 176.91B | ₹ 155.75B | ₹ 137.57B | ₹ 140.69B |
| Total Debt | ₹ 20.47B | ₹ 13.81B | ₹ 14.18B | ₹ 13.97B | ₹ 26.68B |
| Net Debt | ₹ 17.99B | ₹ 10.77B | ₹ 9.63B | ₹ 11.23B | ₹ 24.36B |
| Total Liabilities | ₹ 65.24B | ₹ 52.57B | ₹ 48.60B | ₹ 43.22B | ₹ 52.22B |
| Stockholders' Equity | ₹ 138.20B | ₹ 119.85B | ₹ 103.12B | ₹ 90.45B | ₹ 86.38B |
| Cash Flow | |||||
| Free Cash Flow | ₹ 13.46B | ₹ 12.37B | ₹ 16.89B | ₹ 14.50B | ₹ 7.72B |
| Operating Cash Flow | ₹ 19.63B | ₹ 19.13B | ₹ 19.48B | ₹ 16.82B | ₹ 11.11B |
| Investing Cash Flow | ₹ -16.67B | ₹ -12.99B | ₹ -10.09B | ₹ 1.13B | ₹ -14.35B |
| Financing Cash Flow | ₹ -5.03B | ₹ -8.11B | ₹ -11.45B | ₹ -17.61B | ₹ 3.80B |
Currency in INR
